Gynecologic oncology

The most recent articles from: Gynecol. Oncol. February 2012

Gynecologic oncology · Feb 2012

Randomized Controlled Trial Comparative Study

An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer.

Compared with every-3-week paclitaxel (q3T) plus carboplatin, dose-dense weekly paclitaxel (ddT) plus carboplatin improved the survival of ovarian cancer patients. We performed a cost analysis comparing these two regimens. ⋯ In this economic model, dose-dense weekly paclitaxel is a cost-effective treatment option for advanced ovarian cancer.

explore more… mark as read…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!